Cargando…
FORGE: A Novel Scoring System to Predict the MIB-1 Labeling Index in Intracranial Meningiomas
SIMPLE SUMMARY: Meningiomas are predominantly benign intracranial tumors, and surgical therapy represents the treatment of choice. However, the risk of recurrence and scheduling of follow-up intervals are significantly influenced by immunohistochemical items such as the MIB-1 labeling index. To date...
Autores principales: | Wach, Johannes, Lampmann, Tim, Güresir, Ági, Schuss, Patrick, Vatter, Hartmut, Herrlinger, Ulrich, Becker, Albert, Hölzel, Michael, Toma, Marieta, Güresir, Erdem |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8306435/ https://www.ncbi.nlm.nih.gov/pubmed/34298854 http://dx.doi.org/10.3390/cancers13143643 |
Ejemplares similares
-
Increased MIB-1 Labeling Index Is Associated with Abducens Nerve Morbidity in Primary Sporadic Petroclival Meningioma Surgery: Beyond Location and Approach
por: Wach, Johannes, et al.
Publicado: (2022) -
Combining FORGE Score and Histopathological Diagnostic Criteria of Atypical Meningioma Enables Risk Stratification of Tumor Progression
por: Wach, Johannes, et al.
Publicado: (2021) -
Inflammatory Tumor Microenvironment in Cranial Meningiomas: Clinical Implications and Intraindividual Reproducibility
por: Wach, Johannes, et al.
Publicado: (2022) -
MAC-spinal meningioma score: A proposal for a quick-to-use scoring sheet of the MIB-1 index in sporadic spinal meningiomas
por: Wach, Johannes, et al.
Publicado: (2022) -
Predictive Power of MIB-1 vs. Mitotic Count on Progression-Free Survival in Skull-Base Meningioma
por: Lampmann, Tim, et al.
Publicado: (2022)